Kestra Medical Technologies (KMTS) Receivables - Net (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Receivables - Net data on file, last reported at $12.7 million in Q1 2026.

• Quarterly Receivables - Net rose 60.29% year-over-year to $12.7 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $12.7 million (up 60.29% YoY) and the FY2025 annual result came in at $8.1 million, up 304.45% from the prior year.
• Receivables - Net climbed to $12.7 million in Q1 2026 per KMTS's latest filing, from $10.4 million in the prior quarter.
• Across five years, Receivables - Net topped out at $12.7 million in Q1 2026 and bottomed at $2.0 million in Q2 2024.
• The 3-year median for Receivables - Net is $8.7 million (2025), against an average of $8.4 million.
• The widest annual swing landed in 2025, when Receivables - Net surged 304.45%; it then soared 60.29% in 2026.
• Tracing KMTS's Receivables - Net over 3 years: stood at $2.0 million in 2024, then jumped by 421.17% to $10.4 million in 2025, then advanced by 22.05% to $12.7 million in 2026.
• Per Business Quant, the three latest KMTS Receivables - Net figures stand at $12.7 million (Q1 2026), $10.4 million (Q4 2025), and $9.2 million (Q3 2025).

Peer Comparison